Related Experiment Video
Updated: Jun 10, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
[Autoimmune hepatitis: diagnostic and therapeutic up-to-date]
1Service d'hépatologie, hôpital Saint-Antoine, faculté de médecine Pierre-et-Marie-Curie, 184, rue du Faubourg-Saint-Antoine, 75571 Paris cedex 12, France.
Autoimmune hepatitis is an immune disorder affecting the liver, diagnosed by autoantibodies and liver inflammation. Treatment with corticosteroids and azathioprine is effective but often requires long-term management due to high relapse rates.
Area of Science:
- Hepatology
- Immunology
- Internal Medicine
Context:
- Autoimmune hepatitis (AIH) is a chronic liver disease of unknown cause.
- It affects all age groups, with a higher prevalence in females.
- Presentation varies from asymptomatic to acute liver failure.
Purpose:
- To outline the diagnostic criteria for autoimmune hepatitis.
- To describe the classification of AIH based on autoantibody profiles.
- To review current treatment strategies and management challenges.
Summary:
- Diagnosis relies on elevated serum gammaglobulins, specific autoantibodies (ANA, SMA, LKM1), and liver biopsy findings (inflammation, necrosis).
- AIH is classified into Type 1 (ANA/SMA positive) and Type 2 (LKM1 positive), with mixed forms also recognized.
- Standard treatment involves corticosteroids and azathioprine, achieving remission but often leading to relapse upon discontinuation.
Impact:
- Distinguishing AIH from other hepatitis types is crucial for appropriate therapy.
- Long-term management requires careful monitoring due to frequent relapses (80%) and potential side effects.
- Discontinuation of therapy may be considered after achieving sustained remission (≥2 years) with minimal residual inflammation.
Related Concept Videos
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Viral Hepatitis I: Introduction
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
